UlrichSpecksMD

Pulmonology • Rochester, MN

Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease

Chair, Division of Pulmonary & Critical Care Medicine, Mayo Clinic Rochester

Join to view full profile

Dr. Specks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Specks' full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1986
University of Bonn Faculty of MedicineClass of 1981

Certifications & Licensure

MN State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Start of enrollment: 2005 Jan 01
Completed
Phase 2, Phase 3
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis Start of enrollment: 2006 Apr 01
Recruiting
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis Start of enrollment: 2006 Apr 01
Completed
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis Start of enrollment: 2010 May 01
Completed
Phase 3
One-Time DNA Study for Vasculitis Start of enrollment: 2010 Oct 01
Recruiting
The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach Start of enrollment: 2014 Feb 01
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Identification of the central tolerance checkpoint for autoreactive proteinase 3B cells in human bone marrow.
Alvise Berti, Michele Tomasi, Isabella Pesce, Enrico Lista, Anna Guella
Journal of Autoimmunity. 2024-12-01
Association Between Antiphospholipid Antibodies and Diffuse Alveolar Hemorrhage Risk in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Mariana González-Treviño, Gabriel Figueroa-Parra, Jeffrey X Yang, Larry J Prokop, Sherif M Gamal
Rheumatology. 2024-11-18
A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis.
Cyril Varghese, Geoffrey B Johnson, Patrick W Eiken, Eric S Edell, Ulrich Specks
Annals of the American Thoracic Society. 2024-11-01

Journal Articles

Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features
Zachary M Dong, Michael E Wechsler, Praveen Akuthota, Peter A Merkel, Ulrich Specks, Benjamin Raby, Frederic Clayton, The American Journal of Pathology

Other

Cyclophosphamide pulmonary toxicity
Specks U
http://www.uptodate.com/contents/cyclophosphamide-pulmonary-toxicity
UpToDate, Wolters Kluwer Health - 2012-10-18

Press Mentions

Substudy of ADVOCATE Trial for ANCA-Associated Vasculitis Finds Avacopan Reduces Need for Glucocorticoids, Respiratory and ENT InvolvementMay 9th, 2022
Vasculitis Guidelines in Focus, Part 3: EGPASeptember 14th, 2021
Researchers Identify Possible New Treatment for Severe VasculitisJuly 14th, 2010